Paul Frankenbach/LinkedIn
Sep 2, 2026, 17:22
Paul Frankenbach: New Insights into the Signaling Pathways of Antiphospholipid Antibodies at ISTH 2026
Paul Frankenbach, PhD Candidate at University Medical Center Mainz, shared a post on LinkedIn:
”I had the opportunity to present my research on the critical signaling pathways of different antiphospholipid antibodies at the International Society on Thrombosis and Haemostasis (ISTH) in Paris.
I am very grateful for the support from my supervisors Nadine Müller-Calleja and Wolfram Ruf, my co-authors and the DFG!
It was wonderful to connect with so many experts, exchange ideas, find new friends, and receive valuable feedback on my work.
Looking forward to continuing these discussions in the coming years!”
Stay updated with Hemostasis Today.
-
Oct 18, 2026, 13:0810 Posts Not to Miss This Week
-
Oct 18, 2026, 12:58Pierpaolo Di Micco: DOACs vs Vitamin K Antagonists in Long-Term Anticoagulation
-
Oct 18, 2026, 12:51Arianne Missimer: Understanding Ferritin Levels Beyond the Normal Range
-
Oct 18, 2026, 12:37Roberto C. Iglesias: Colon Cancer Prevention Beyond Supplements and Vitamins
-
Oct 18, 2026, 12:27Rafael Alejandro Camero Del Vecchio: Paroxysmal Nocturnal Hemoglobinuria Advancing Complement Inhibition with Ravulizumab
-
Oct 18, 2026, 12:26Abdul Mannan: When INR Misleads – Rethinking Bleeding Risk in Cirrhosis
-
Oct 18, 2026, 12:14Stéphane Laurent: The People and Technology Behind Safe Blood Transfusion
-
Oct 18, 2026, 12:14Abhi Kapuria: When VTE Prophylaxis Breaks Down in the ICU
-
Oct 18, 2026, 11:37Lee Anne Sorto: Beyond Compliance – Making Audits Count in Transfusion Safety